IDACIO
IDACIO
Approved
DIN Number
02502674
Drug Class
Human
Market Date
Feb 16, 2021
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502674
AIG Number0150364003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADALIMUMABActive
Strength: 40 MG / 0.8 ML
Monograph: ADALIMUMAB